2008 U.S. Food and Drug Administration Critical Path Workshop. Clinical trials for local treatment of breast cancer by thermal ablation

 


Quick Links

Critical Path Initiative

Contact Information

Click to download PowerPoint Viewer:

Powerpoint Viewer

Click to view speaker-specific presentations:

Donna-Bea Tillman, Ph.D.
Keynote Address: FDA's Role in Medical Device Innovation

Binita Ashar, M.D., M.B.A., FACS
Introduction to the Workshop

Keyvan Farahani, Ph.D.
Perspectives of NCI's Image-Guided Intervention Branch

Ted Trimble, M.D., M.P.H.
Perspectives of NCI's Cancer Therapy Evaluation Program

Rache Simmons, M.D.
Cryoablation

Mitch Schnall, M.D.
High-Intensity Focused Ultrasound

Kambiz Dowlat, M.D.
Interstitial Laser

Suzanne Klimberg, M.D.
Radiofrequency Ablation

Alan Fenn, Ph.D.
Microwave Ablation

Lakshmi Vishnuvajjala, Ph.D.
Considerations When Validating a Biomarker

Kenneth Bloom, M.D.
Overview of Ablated Breast Tumor Pathology

Long Chen, Ph.D.
How a Patient Registry May Help to Implement a Standardized Framework for Feasibility Trials: Comments Received by FDA

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Sponsored by the FDA: September 15, 2008 | FDA White Oak Campus | Building 21 | 10903 New Hampshire Avenue | Silver Spring, MD 20993
Register Online Now!  Registration Quick Link